Financials

  • Market Capitalization 22.59 M
  • Employee 5
  • Founded 1979
  • CEO N/A
  • Website www.dyadic.com
  • Headquarter Delaware, United States
  • FIGI BBG000L276R1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.09
Relación precio/flujo de caja
9.92

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4516
MRKR
Marker Therapeutics, Inc. - Common Stock
1.38 USD-5.48%-0.72%+15.97%+40.82%23.01 M USD
4530
KZIA
Kazia Therapeutics Limited - American Depositary Shares
13.59 USD-19.59%+1.34%+8.03%+132.31%22.00 M USD
4532
ALLR
Allarity Therapeutics, Inc. - Common stock
1.42 USD+2.90%0.00%+14.52%-16.47%22.59 M USD
4533
ABVC
ABVC BioPharma, Inc. - Common Stock
0.83 USD+3.75%-6.74%-22.43%-73.48%22.12 M USD

Noticias